{'52WeekChange': -0.123938024,
 'SandP52WeekChange': None,
 'address1': '1555 Adams Drive',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 17.15,
 'askSize': 4000,
 'averageDailyVolume10Day': 316050,
 'averageVolume': 502930,
 'averageVolume10days': 316050,
 'beta': 1.20168,
 'beta3Year': None,
 'bid': 17.14,
 'bidSize': 2200,
 'bookValue': 3.315,
 'category': None,
 'circulatingSupply': None,
 'city': 'Menlo Park',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 17.64,
 'dayLow': 17.11,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -10.146,
 'enterpriseToRevenue': 4.702,
 'enterpriseValue': 480961952,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 14.768857,
 'fiftyTwoWeekHigh': 31.46,
 'fiftyTwoWeekLow': 5.97,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 29042841,
 'forwardEps': -1.25,
 'forwardPE': -13.719999,
 'fromCurrency': None,
 'fullTimeEmployees': 402,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.040560003,
 'heldPercentInstitutions': 1.01828,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1405036800,
 'lastSplitFactor': '1:4',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/intersectent.com',
 'longBusinessSummary': 'Intersect ENT, Inc., a drug delivery company, '
                        'researches and develops products for the treatment of '
                        'patients with ear, nose, and throat conditions in the '
                        'United States. The company offers PROPEL and PROPEL '
                        'mini drug releasing implants for patients undergoing '
                        'sinus surgery to treat chronic sinusitis; and PROPEL '
                        'Contour, a steroid releasing implant to frontal and '
                        'maxillary sinus ostia, or openings, of the dependent '
                        'sinuses. It is also developing SINUVA, a steroid '
                        'releasing implant for refractory disease for the '
                        'treatment of patients in the physician office '
                        'setting. The company was formerly known as Sinexus, '
                        'Inc. and changed its name to Intersect ENT, Inc. in '
                        'November 2009. Intersect ENT, Inc. was founded in '
                        '2003 and is headquartered in Menlo Park, California.',
 'longName': 'Intersect ENT, Inc.',
 'market': 'us_market',
 'marketCap': 558390272,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_37464681',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -49722000,
 'nextFiscalYearEnd': 1640908800,
 'open': 17.44,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -1.31,
 'phone': '650 641 2100',
 'previousClose': 17.53,
 'priceHint': 2,
 'priceToBook': 5.173454,
 'priceToSalesTrailing12Months': 5.458627,
 'profitMargins': -0.48606,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 17.64,
 'regularMarketDayLow': 17.11,
 'regularMarketOpen': 17.44,
 'regularMarketPreviousClose': 17.53,
 'regularMarketPrice': 17.44,
 'regularMarketVolume': 171492,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 32559200,
 'sharesPercentSharesOut': 0.0423,
 'sharesShort': 1377736,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1625409,
 'shortName': 'Intersect ENT, Inc.',
 'shortPercentOfFloat': 0.0427,
 'shortRatio': 3.63,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'XENT',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.566,
 'twoHundredDayAverage': 16.715252,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'a54023ae-c4e6-36dd-9ce1-7179146fe756',
 'volume': 171492,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.intersectent.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94025'}